The Clinical Caveat for Treating Persistent Hypokalemia in Diabetic Ketoacidosis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The medical community seeks to provide evidence-based guidelines for treating any disease to ensure optimal care delivery. Occasionally, a patient's unique physiology does not respond to guideline-driven treatments and requires experienced clinical personalization for treatment. Failure of clinicians to recognize patient outliers and augment care can delay treatment, provide substandard care, and potentially threaten a patient's life. This paper describes a clinical caveat for treating profound or persistent hypokalemia in patients with DKA (diabetic ketoacidosis).
References
1.
Hursh B, Ronsley R, Islam N, Mammen C, Panagiotopoulos C
. Acute Kidney Injury in Children With Type 1 Diabetes Hospitalized for Diabetic Ketoacidosis. JAMA Pediatr. 2017; 171(5):e170020.
DOI: 10.1001/jamapediatrics.2017.0020.
View
2.
Pasquel F, Tsegka K, Wang H, Cardona S, Galindo R, Fayfman M
. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. Diabetes Care. 2019; 43(2):349-357.
PMC: 6971788.
DOI: 10.2337/dc19-1168.
View
3.
Dhatariya K, Nunney I, Higgins K, Sampson M, Iceton G
. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2015; 33(2):252-60.
DOI: 10.1111/dme.12875.
View
4.
Palmer B, Clegg D
. Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus. N Engl J Med. 2015; 373(6):548-59.
DOI: 10.1056/NEJMra1503102.
View
5.
Syed Z, Kimball T, Ismail M
. Successful Use of Renal Replacement Therapy for Refractory Hypokalemia in a Diabetic Ketoacidosis Patient. Case Rep Crit Care. 2019; 2019:6130694.
PMC: 6710747.
DOI: 10.1155/2019/6130694.
View